Government Support For Biotech Sector Is Insufficient For Growth

BMI Core View: Governments in emerging markets are increasing investment in local biopharmaceutical research and development (R&D), as they become increasingly aware of the importance of this industry sector for promoting economic growth, fostering global competitiveness, as well as reducing the financial burden of disease on local citizens by improving access to innovative medicines.

To read the full article, please choose one of the following options: